Archived Insight | January 8, 2020

How to Use Compensation Survey Data: Segal Shares Insights

Myrna Hellerman, VP at Segal's Chicago office, talks to Chief Executive magazine about how companies should use compensation survey data in order to achieve the best results. Read her insights today!

Read the Interview

Questions about the article?

Get in touch. Our press team will be happy to help.

How to use compensation survey data

Myrna Hellerman speaks with Chief Executive magazine about how the data collected from compensation surveys can help companies with a variety of challenges. To successfully leverage this data, executives not only need to drill into the hard numbers, but also interpret the information collected in a way that's meaningful for their organization.

"Survey users, particularly those who seek insights into private company pay, need to rely on both the 'science' and the 'art' of data analytics."

Read more of her insights in the linked story.

Read the Interview

See more from Segal

Female Nutritionist Holding Image Of Healthy Eating Plate

Health Coaching Enhances Well-Being and Productivity

Your organization can derive significant value from integrating health coaching into its existing health-management programs.

Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Pharmaceutical, Corporate

Read Full Insight

Lawyer And Business Person Discussing In The Office

Supreme Court Addresses Prohibited Transaction Lawsuits

As a result of the Supreme Court’s decision, it will be easier for participants to sue plans for everyday plan transactions with service providers.

Retirement, Compliance, Multiemployer Plans, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Corporate

Read Full Insight

Pharmacist Taking Inventory With Digital Tablet

Executive Order Seeks to Lower Prescription Drug Prices

The order instructs federal departments to issue regulations or work with Congress to identify statutory changes necessary to address drug prices.

Health, Compliance, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Pharmaceutical, Corporate

Read Full Insight

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.